{"entity":{"id":"essen-wtz","kind":"institution","name":"West German Cancer Center (WTZ), University Hospital Essen","aka":["Westdeutsches Tumorzentrum","Universitätsklinikum Essen","NCT West"],"tldr":"One of Germany's oldest and largest cancer centres, home to the West German Proton Therapy Centre and a leading melanoma and theranostics programme.","summary":"Founded in 1967, the Westdeutsches Tumorzentrum at University Hospital Essen was among the first German Cancer Aid Oncology Centers of Excellence and became a National Center for Tumor Diseases site (NCT West, with Cologne) in 2023. It operates the West German Proton Therapy Centre Essen (WPE), Europe's largest university-based proton facility, treating many paediatric patients. The dermato-oncology group under Dirk Schadendorf has led melanoma immunotherapy and adjuvant trials, and the nuclear medicine department under Ken Herrmann is a high-volume theranostics centre for PSMA and somatostatin-receptor radioligands. Other strengths include sarcoma, uveal melanoma, stem cell transplantation and neuro-oncology.","asOf":"2026-09-09","links":[{"label":"Homepage","url":"https://www.wtz-essen.de"},{"label":"WPE proton centre","url":"https://www.wpe-uk.de"},{"label":"NCT West","url":"https://www.nct-west.de"},{"label":"PTCOG: particle therapy facilities in operation","url":"https://www.ptcog.site/index.php/facilities-in-operation-public"}],"tags":[],"related":[],"cancers":["melanoma","prostate","neuroendocrine","sarcoma","aml"],"sections":["radiation","radiopharma","immunotherapy"],"technologies":["proton-therapy","radioligand-therapy","psma-pet","checkpoint-inhibitor","proton-therapy-systems"],"targets":[],"drugs":["pluvicto","lutathera","nivolumab","ipilimumab"],"companies":["iba"],"institutions":["uniklinik-koeln","dkfz"],"pathways":[],"terms":[],"trials":["checkmate-067","vision"],"people":["dirk-schadendorf","martin-schuler","ken-herrmann"],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Essen","country":"DE","lat":51.437,"lng":6.992,"institutionType":"cancer-center","website":"https://www.wtz-essen.de","university":"Universität Duisburg-Essen","programs":["West German Proton Therapy Centre","Melanoma and dermato-oncology","Theranostics and nuclear medicine","Stem cell transplantation","NCT West"]},"route":"/institutions/essen-wtz/","neighbours":{"cancer":[{"id":"aml","kind":"cancer","name":"Acute myeloid leukaemia","route":"/cancers/aml/"},{"id":"melanoma","kind":"cancer","name":"Melanoma","route":"/cancers/melanoma/"},{"id":"neuroendocrine","kind":"cancer","name":"Neuroendocrine tumours","route":"/cancers/neuroendocrine/"},{"id":"prostate","kind":"cancer","name":"Prostate cancer","route":"/cancers/prostate/"},{"id":"sarcoma","kind":"cancer","name":"Sarcomas (soft tissue, bone, GIST)","route":"/cancers/sarcoma/"}],"section":[{"id":"immunotherapy","kind":"section","name":"Immunotherapy","route":"/fronts/immunotherapy/"},{"id":"radiation","kind":"section","name":"Radiation Therapy","route":"/fronts/radiation/"},{"id":"radiopharma","kind":"section","name":"Radiopharmaceuticals & Theranostics","route":"/fronts/radiopharma/"}],"technology":[{"id":"checkpoint-inhibitor","kind":"technology","name":"Immune checkpoint inhibitors","route":"/technologies/checkpoint-inhibitor/"},{"id":"proton-therapy","kind":"technology","name":"Proton therapy","route":"/technologies/proton-therapy/"},{"id":"proton-therapy-systems","kind":"technology","name":"Proton therapy machines: cyclotrons, synchrotrons and single-room systems","route":"/technologies/proton-therapy-systems/"},{"id":"psma-pet","kind":"technology","name":"PSMA PET","route":"/technologies/psma-pet/"},{"id":"radioligand-therapy","kind":"technology","name":"Radioligand therapy (beta emitters)","route":"/technologies/radioligand-therapy/"}],"drug":[{"id":"ipilimumab","kind":"drug","name":"Ipilimumab","route":"/drugs/ipilimumab/"},{"id":"lutathera","kind":"drug","name":"Lutetium-177 dotatate","route":"/drugs/lutathera/"},{"id":"pluvicto","kind":"drug","name":"Lutetium-177 vipivotide tetraxetan","route":"/drugs/pluvicto/"},{"id":"nivolumab","kind":"drug","name":"Nivolumab","route":"/drugs/nivolumab/"}],"company":[{"id":"iba","kind":"company","name":"IBA (Ion Beam Applications)","route":"/companies/iba/"}],"institution":[{"id":"deutsche-krebsgesellschaft","kind":"institution","name":"Deutsche Krebsgesellschaft","route":"/institutions/deutsche-krebsgesellschaft/"},{"id":"dktk","kind":"institution","name":"German Cancer Consortium (DKTK)","route":"/institutions/dktk/"},{"id":"dkfz","kind":"institution","name":"German Cancer Research Center (DKFZ)","route":"/institutions/dkfz/"},{"id":"kliniken-essen-mitte","kind":"institution","name":"Kliniken Essen-Mitte","route":"/institutions/kliniken-essen-mitte/"},{"id":"uniklinik-koeln","kind":"institution","name":"Uniklinik Köln (CIO)","route":"/institutions/uniklinik-koeln/"}],"trial":[{"id":"checkmate-067","kind":"trial","name":"CheckMate 067","route":"/trials/checkmate-067/"},{"id":"vision","kind":"trial","name":"VISION","route":"/trials/vision/"}],"person":[{"id":"dirk-schadendorf","kind":"person","name":"Dirk Schadendorf","route":"/people/dirk-schadendorf/"},{"id":"ken-herrmann","kind":"person","name":"Ken Herrmann","route":"/people/ken-herrmann/"},{"id":"martin-schuler","kind":"person","name":"Martin Schuler","route":"/people/martin-schuler/"},{"id":"sebastian-bauer","kind":"person","name":"Sebastian Bauer","route":"/people/sebastian-bauer/"}]}}